- Home
- BILI vs PEN Comparison
BILI vs PEN Comparison
Compare BILI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BILI | PEN |
|---|---|---|
| Founded | 2009 | 2004 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1B | 14.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | BILI | PEN |
|---|---|---|
| Price | $26.06 | $339.78 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 17 |
| Target Price | $30.00 | ★ $357.33 |
| AVG Volume (30 Days) | ★ 2.0M | 588.2K |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | N/A | ★ $1,403,665,000.00 |
| Revenue This Year | $11.00 | $14.20 |
| Revenue Next Year | $8.92 | $13.60 |
| P/E Ratio | $122.37 | ★ $74.92 |
| Revenue Growth | N/A | ★ 17.50 |
| 52 Week Low | $14.47 | $221.26 |
| 52 Week High | $36.40 | $362.41 |
Technical Indicators
Market Signals| Indicator | BILI | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 37.17 | 49.63 |
| Support Level | $25.73 | $338.08 |
| Resistance Level | $27.90 | $344.07 |
| Average True Range (ATR) | 0.77 | 2.27 |
| MACD | -0.51 | -0.70 |
| Stochastic Oscillator | 22.33 | 32.55 |
Price Performance
Historical ComparisonAbout BILI Bilibili Inc.
Bilibili is a Chinese online entertainment platform best known for its YouTube-like video-sharing site. Founded in 2009, it initially focused on long-form content centered around anime, comics, and gaming, catering primarily to Gen Z users. Over time, the platform has broadened its content offerings to include a wider range of interests, successfully attracting a more diverse audience beyond the Gen Z demographic.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.